Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Explore this paper's citation graph
- Type
- article
- Published
- 2019-01-01
- Cited by
- 3,162
- References
- 175
- Access
- Open access
- OpenAlex
- https://openalex.org/W2915809836
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:86528128
Keywords
Medicine, Guideline, Grading (engineering), Systematic review, MEDLINE
References
- Improving liver allocation: MELD and PELD
- Prospective validation of the Barcelona Clinic Liver Cancer staging system.
- New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma.
- Local Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma: Treatment Choice and Outcome
- Improved detection of hepatocellular carcinoma using a longitudinal α-fetoprotein screening algorithm
- A Manual for Assessing Health Practices & Designing Practice Policies: The Explicit Approach
- Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma
- Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study
- Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System
- Brivanib as adjuvant therapy to transarterial chemoembolization in patients with hepatocellular carcinoma: A randomized phase III trial
- Cabozantinib: a MET, RET, and VEGFR2 tyrosine kinase inhibitor.
- How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations.
- Downstaging of Hepatocellular Cancer before Liver Transplant: Long-term Outcome compared to Tumors within Milan Criteria
- Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience
- Cell-surface Vimentin (csVim): A mislocalized protein for isolating csVimentin+CD133− novel stem-like hepatocellular carcinoma cells expressing EMT markers
- Establishment of a Multidisciplinary Hepatocellular Carcinoma Clinic is Associated with Improved Clinical Outcome
- Alcohol and hepatocellular carcinoma.
- Yttrium‐90 radioembolization vs sorafenib for intermediate‐locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis
- Non-Alcoholic Fatty Liver Disease and Hepatocellular Cancer: A Systematic Review
- Detection of Hepatocellular Carcinoma at Advanced Stages Among Patients in the HALT-C Trial: Where Did Surveillance Fail?
Cited by
- Liver Function—How to Screen and to Diagnose: Insights from Personal Experiences, Controlled Clinical Studies and Future Perspectives
- Therapeutic evaluation of arterio-portal fistula-related gastroesophageal variceal bleeding
- Does the dose and type of nonselective beta‐blocker really matter?
- Beta‐blockers in patients with advanced liver disease: Has the dust settled?
- Do we need vasoconstrictors up to 5 days after successful hemostasis by ligation of bleeding varices?
- Hospital volume and mortality after transjugular intrahepatic portosystemic shunt creation in the United States
- The use of non-selective beta-blockers in patients with cirrhosis: more doubts than certainties
- Impact of beta‐blockers on cardiopulmonary exercise testing in patients with advanced liver disease
- Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C
- VARICEAL BLEEDING: UPDATE OF RECOMMENDATIONS FROM THE BRAZILIAN ASSOCIATION OF HEPATOLOGY.
- Beta-Blockers in Hospitalized Patients with Cirrhosis and Ascites: Mortality and Factors Determining Discontinuation and Re-initiation
- Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)
- Endoscopic Therapy for Variceal Bleeding: from Patient Preparation to Available Techniques and Rescue Therapies
- Biology of portal hypertension
- Transjugular portal vein recanalization with creation of intrahepatic portosystemic shunt (PVR-TIPS) in patients with chronic non-cirrhotic, non-malignant portal vein thrombosis
- Advances and challenges in cirrhosis and portal hypertension
- Favorable Effects of Endoscopic Ligation Combined with Drugs on Rebleeding and Mortality in Cirrhotic Patients: A Network Meta-Analysis
- Who should receive endoscopic variceal ligation after recovering from acute variceal bleeding?
- Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis
- The risk of cirrhosis in non-alcohol drinkers is greater in female than male betel nut chewers
Related papers
- EXCELLENT ELEMENTS OF PRESENTATION IN BUSINESS ARENA
- Chapters 1-3
- Chapters 6-7
- [The guideline for the treatment of mood disorders in USA and Japan].
- Effects of the Guideline of Community-aquired Pneumonia on the Achievement Ratio of CAP Therapy
- [Summary of the practice guideline for shoulder complaints from the Dutch College of General Practitioners].
- Locating and appraising systematic reviews.
- Comparison of search strategies in systematic reviews of adverse effects to other systematic reviews.